14h
Hosted on MSNGoldman Sachs Initiates Coverage of Summit Therapeutics (SMMT) with Buy RecommendationFintel reports that on February 28, 2025, Goldman Sachs initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy ...
The Santa Fe County sheriff said the actor’s pacemaker was inspected and last showed activity nine days before his and his ...
ALBAWABA - On Friday, investigators said Gene Hackman and his wife died nine days before their remains were located in their ...
Join STAT and Takeda on March 25 to explore how plasma-derived therapies are reshaping healthcare. Register now for this ...
23h
Zacks.com on MSNMerck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?Merck MRK stock has declined 7.8% in the past month — in roughly the span after it announced fourth-quarter 2024 results and ...
Incyte today announced that multiple abstracts featuring new data from its dermatology portfolio will be presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting, being held March 7?
The Interministerial Commission for the Pricing of Medicines in Spain has backed access by the Spanish National Health System ...
Unique, patient-focused manufacturing models are needed to scale up innovative cell therapies for cancer and one company, ...
Backed by the strengths India has had the efficient delivery of medicines and healthcare services, Umang Vohra from Cipla ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...
Piper Sandler analyst Yasmeen Rahimi initiated coverage on Avalo Therapeutics, Inc. AVTX with an Overweight rating and ...
Pharmaceutical company Summit Therapeutics is standing out today, surging to $20.45 and marking a 10.6% change. In comparison ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results